| 1 |
Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6): 421-430.
|
| 2 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
| 3 |
Boers E, Barrett M, Su JG, et al. Global burden of chronic obstructive pulmonary disease through 2050[J]. JAMA Netw Open, 2023, 6(12): e2346598.
|
| 4 |
Yu W, Lan Y, Sun D, et al. Prevalence and risk factors for chronic obstructive pulmonary disease among adults aged 50 and above - 10 CKB study areas, China, 2020-2021[J]. China CDC Wkly, 2024, 6(43): 1126-1131.
|
| 5 |
de Oca MM, Perez-Padilla R, Celli B, et al. The global burden of COPD: epidemiology and effect of prevention strategies[J]. Lancet Respir Med, 2025, 13(8): 709-724.
|
| 6 |
Muñoz-Bermejo L, Adsuar JC, Mendoza-Muñoz M, et al. Test-retest reliability of five times sit to stand test (FTSST) in adults: A systematic review and Meta-analysis[J]. Biology(Basel), 2021, 10(6): PMID: 34207604
|
| 7 |
Jones SE, Kon SS, Canavan JL, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD[J]. Thorax, 2013, 68(11): 1015-1020.
|
| 8 |
Medina-Mirapeix F, Bernabeu-Mora R, Valera-Novella E, et al. The five-repetition sit-to-stand test is a predictive factor of severe exacerbations in COPD[J]. Ther Adv Chronic Dis, 2021, 12: 2040622320986718.
|
| 9 |
Medina-Mirapeix F, Valera-Novella E, Morera-Balaguer J, et al. Prognostic value of the five-repetition sit-to-stand test for mortality in people with chronic obstructive pulmonary disease[J]. Ann Phys Rehabil Med, 2022, 65(5): 101598.
|
| 10 |
Machado A, Dias C, Rebelo P, et al. Functional capacity using sit-to-stand tests in people with chronic obstructive pulmonary disease and its relationship with disease severity-a cross-sectional study with matched controls[J]. Braz J Phys Ther, 2024, 28(4): 101090.
|
| 11 |
Lei X, Sun X, Strauss J, et al. Health outcomes and socio-economic status among the mid-aged and elderly in China: Evidence from the CHARLS national baseline data[J]. J Econ Ageing, 2014, 4: 59-73.
|
| 12 |
Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS) [J]. Int J Epidemiol, 2014, 43(1): 61-68.
|
| 13 |
Feng GY, Li JX, Li GS, et al. Association between frailty status and risk of chronic lung disease: an analysis based on two national prospective cohorts[J]. Aging Clin Exp Res, 2024, 36(1): 215.
|
| 14 |
Li YH, Wang XH, Ya S, et al. The optimal cut-off value of five-time chair stand test for assessing sarcopenia among Chinese community-dwelling older adults[J]. J Cachexia Sarcopenia Muscle, 2024, 15(2): 756-764.
|
| 15 |
Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults[J]. Jama, 2011, 305(1): 50-58.
|
| 16 |
Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants[J]. Bmj, 2018, 361: k1651.
|
| 17 |
McGrath RP, Kraemer WJ, Snih SA, et al. Handgrip strength and health in aging adults[J]. Sports Med, 2018, 48(9): 1993-2000.
|
| 18 |
Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646.
|
| 19 |
Dent E, Martin FC, Bergman H, et al. Management of frailty: opportunities, challenges, and future directions[J]. Lancet, 2019, 394(10206): 1376-1386.
|
| 20 |
Landi F, Salini S, Zazzara MB, et al. Relationship between pulmonary function and physical performance among community-living people: results from Look-up 7+ study[J]. J Cachexia Sarcopenia Muscle, 2020, 11(1): 38-45.
|
| 21 |
Cao Z, Xu C, Zhang P, et al. Associations of sedentary time and physical activity with adverse health conditions: Outcome-wide analyses using isotemporal substitution model[J]. E Clin Med, 2022, 48: 101424.
|
| 22 |
Hanlon P, Lewsey J, Quint JK, et al. Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank[J]. BMJ Open Respir Res, 2022, 9(1): e001314.
|
| 23 |
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission[J]. J Gerontol, 1994, 49(2): M85-M94.
|
| 24 |
Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: A literature review[J]. Respir Med, 2017, 128: 70-77.
|
| 25 |
Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study[J]. Chest, 2011, 140(2): 331-342.
|
| 26 |
孔令梅,徐晓媛,马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(3): 407-410.
|
| 27 |
徐艳,江秀娟,王超,等. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(3): 454-457.
|
| 28 |
Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD[J]. J Appl Physiol, 2013, 114(9): 1222-1234.
|
| 29 |
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2016, 138(1): 16-27.
|
| 30 |
Henrot P, Dupin I, Schilfarth P, et al. Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting[J]. Int J Mol Sci, 2023, 24(7): 6454.
|